Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-28 Sale | 2023-08-29 5:04 pm | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $6.2757 | $98,058 | 148,975 (Direct) | View |
2023-06-23 Sale | 2023-06-23 7:15 pm | Reneo Pharmaceuticals Inc. | RPHM | Novo Holdings A/S 10% Owner | 100,000 | $7.0974 | $709,740 | 3,330,337 (Direct) | View |
2023-05-08 Purchase | 2023-05-10 5:47 pm | Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director | 125,000 | $8 | $1,000,000 | 2,188,713 (Indirect) | View |
2022-09-01 Purchase | 2022-09-02 5:12 pm | Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer | 7,500 | $3.393 | $25,448 | 45,455 (Indirect Direct) | View |
2022-08-29 Purchase | 2022-08-31 5:47 pm | Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer | 7,255 | $3.2038 | $23,243 | 37,955 (Indirect Direct) | View |
2021-08-25 Purchase | 2021-08-26 5:54 pm | Reneo Pharmaceuticals Inc. | RPHM | Jindal Vineet R. Chief Financial Officer | 5,000 | $7.4353 | $37,177 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-08-28 Exercise | 2023-08-29 5:04 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $0 | 148,975 (Direct) | View |
2023-08-28 Exercise | 2023-08-29 5:04 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $1.8 | 148,975 (Direct) | View |
2023-07-26 Gift | 2023-07-27 5:16 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman | 50,000 | $0 | 628,846 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 8:09 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:17 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Blunt Roshawn A. Director | 14,815 | $0 | 14,815 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:16 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:15 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:14 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:13 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:06 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Seltzer Stacey Denenberg Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:02 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director | 17,500 | $0 | 17,500 (Direct) | View |
2022-12-09 Option Award | 2022-12-13 6:13 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Lam Jennifer VP of Finance & Administration | 90,000 | $0 | 110,600 (Direct) | View |
2022-12-09 Option Award | 2022-12-13 6:11 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 125,000 | $0 | 160,600 (Direct) | View |
2022-12-09 Option Award | 2022-12-13 6:09 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | FLESHER GREGORY J. President and CEO | 300,000 | $0 | 415,200 (Direct) | View |
2022-12-09 Option Award | 2022-12-13 6:07 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Dorenbaum Alejandro Chief Medical Officer | 125,000 | $0 | 155,000 (Direct) | View |
2022-08-12 Gift | 2022-12-13 6:07 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Dorenbaum Alejandro Chief Medical Officer | 22,348 | $0 | 155,000 (Direct) | View |
2022-12-09 Option Award | 2022-12-13 6:06 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer | 125,000 | $0 | 174,455 (Direct) | View |
2022-08-31 Exercise | 2022-09-02 5:10 pm | 2019-01-01 2028-04-04 | Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman | 50,000 | $0 | 696,252 (Direct) | View |
2022-08-31 Exercise | 2022-09-02 5:10 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman | 50,000 | $1.97 | 696,252 (Direct) | View |
2022-08-02 Option Award | 2022-08-02 7:16 pm | N/A 2032-08-01 | Reneo Pharmaceuticals Inc. | RPHM | Blunt Roshawn A. Director | 35,000 | $0 | 35,000 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:26 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director | 17,500 | $0 | 17,500 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:01 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | GREY MICHAEL G Executive Chairman | 17,500 | $0 | 17,500 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:00 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director | 6,376 | $0 | 6,376 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:00 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | Dube Eric M Director | 17,500 | $0 | 17,500 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:00 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | Muralidhar Bali Director | 17,500 | $0 | 17,500 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:00 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | Seltzer Stacey Denenberg Director | 17,500 | $0 | 17,500 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:00 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | O'Donnell Niall Director | 17,500 | $0 | 17,500 (Direct) | View |
Ownership | 2022-04-05 8:02 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Lam Jennifer VP of Finance & Administration | 0 | $0 | 110,000 (Direct) | View |
2022-03-02 Option Award | 2022-03-04 9:51 pm | N/A 2032-03-01 | Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Chief Operating Officer | 25,000 | $0 | 25,000 (Direct) | View |
2022-01-20 Option Award | 2022-01-24 4:58 pm | N/A 2032-01-19 | Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director | 35,000 | $0 | 35,000 (Direct) | View |
2021-12-10 Option Award | 2021-12-14 4:32 pm | N/A 2031-12-09 | Reneo Pharmaceuticals Inc. | RPHM | Jindal Vineet R. Chief Financial Officer | 130,000 | $0 | 136,600 (Direct) | View |
2021-12-10 Option Award | 2021-12-14 4:31 pm | N/A 2031-12-09 | Reneo Pharmaceuticals Inc. | RPHM | FLESHER GREGORY J. President and CEO | 300,000 | $0 | 309,600 (Direct) | View |
2021-12-10 Option Award | 2021-12-14 4:30 pm | N/A 2031-12-09 | Reneo Pharmaceuticals Inc. | RPHM | Dorenbaum Alejandro Chief Medical Officer | 130,000 | $0 | 152,348 (Direct) | View |
2021-12-10 Option Award | 2021-12-14 4:28 pm | N/A 2031-12-09 | Reneo Pharmaceuticals Inc. | RPHM | Cruse Michael Senior VP-Corporate Operations | 100,000 | $0 | 104,100 (Direct) | View |
2021-11-12 Option Award | 2021-11-15 7:49 pm | N/A 2031-11-11 | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 210,000 | $0 | 210,000 (Direct) | View |